The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial

OBJECTIVE: Intrathecal baclofen treatment is used for the treatment of dystonia in patients with severe dyskinetic cerebral palsy; however, the current level of evidence for the effect is low. The primary aim of this study was to provide evidence for the effect of intrathecal baclofen treatment on i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonouvrié, Laura A., Becher, Jules G., Vles, Johan S. H., Vermeulen, R. Jeroen, Buizer, Annemieke I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617761/
https://www.ncbi.nlm.nih.gov/pubmed/31050023
http://dx.doi.org/10.1002/ana.25498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617761/
https://www.ncbi.nlm.nih.gov/pubmed/31050023
http://dx.doi.org/10.1002/ana.25498

Ejemplares similares